Paul Manos

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12

CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

Mark H. Wilcox, G. Ralph Corey, George H. Talbot et al. · Journal of Antimicrobial Chemotherapy · 2010 · 215 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia

Thomas M. File, Donald E. Low, Paul B. Eckburg et al. · Journal of Antimicrobial Chemotherapy · 2011 · 196 citations · Full text

Medicine, Infectious Diseases, Pharmacology +13

A randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infections

William O’Riordan, Purvi Mehra, Paul Manos et al. · International Journal of Infectious Diseases · 2014 · 98 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: Summary of Safety Analysis from the Phase 3 SOLO Studies

G. Ralph Corey, Jeffery S. Loutit, Greg Moeck et al. · Antimicrobial Agents and Chemotherapy · 2018 · 25 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13